Open original FDA record ↗Recall record
- FDA identifier
- Z-1355-2015
- Company in FDA record
- Boston Scientific Corporation
- FDA classification date
- Mar 31, 2015
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Complaints of device fragmentation after the catheter was implanted in the biliary system. The most serious patient risk for this issue is additional intervention for fragment retrieval using minimally invasive methods and, in some of the reported cases, this was performed to retrieve the device fragments.
Source facts
- Action
- Boston Scientific sent an Urgent Medical Device Correction - Immediate Action Required letter dated February 5, 2015. to all affected customers. The letter identified the product the problem and the action needed to be taken by the customer. The letter described the problem and the product involved in the recall. Advised consignees to complete and return the "Recall Removal Reply Verification Tracking Form". Your local Sales Representative can answer any questions you may have regarding this Field Correction notice. For further questions please call (763) 494- 7971.
- Initiated
- 2015-02-25
- Root cause
- Device Design
- Terminated
- 2017-06-30
- Distribution
- Worldwide Distribution - US Distribution to the states of : CA, WI, FL and OH., and to the countries of: Belgium, Czech Republic, Finland, France, Germany, Great Britain, Italy, Spain, Switzerland, Austria, Hungary, Netherlands and Portugal.
- Recall number
- Z-1355-2015
- Recall status
- Terminated
- CDRH record ID
- 134146
- FDA classified
- 2015-03-31
- Recall event number
- 70604